annual EBITDA:
-$383.98M-$237.02M(-161.29%)Summary
- As of today (June 23, 2025), BEAM annual EBITDA is -$383.98 million, with the most recent change of -$237.02 million (-161.29%) on December 31, 2024.
- During the last 3 years, BEAM annual EBITDA has risen by +$1.04 million (+0.27%).
- BEAM annual EBITDA is now -435.90% below its all-time high of -$71.65 million, reached on December 31, 2019.
Performance
BEAM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$113.76M-$28.83M(-33.95%)Summary
- As of today (June 23, 2025), BEAM quarterly EBITDA is -$113.76 million, with the most recent change of -$28.83 million (-33.95%) on March 31, 2025.
- Over the past year, BEAM quarterly EBITDA has dropped by -$15.06 million (-15.26%).
- BEAM quarterly EBITDA is now -177.00% below its all-time high of $147.74 million, reached on December 31, 2023.
Performance
BEAM quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$399.03M-$15.06M(-3.92%)Summary
- As of today (June 23, 2025), BEAM TTM EBITDA is -$399.03 million, with the most recent change of -$15.06 million (-3.92%) on March 31, 2025.
- Over the past year, BEAM TTM EBITDA has dropped by -$247.66 million (-163.61%).
- BEAM TTM EBITDA is now -462.47% below its all-time high of -$70.94 million, reached on September 30, 2019.
Performance
BEAM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BEAM EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -161.3% | -15.3% | -163.6% |
3 y3 years | +0.3% | -56.0% | -54.1% |
5 y5 years | -435.9% | -317.4% | -361.1% |
BEAM EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -161.3% | +0.3% | -177.0% | at low | -171.5% | at low |
5 y | 5-year | -435.9% | +0.3% | -177.0% | +42.8% | -361.1% | at low |
alltime | all time | -435.9% | +0.3% | -177.0% | +42.8% | -462.5% | at low |
BEAM EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$113.76M(+33.9%) | -$399.03M(+3.9%) |
Dec 2024 | -$383.98M(+161.3%) | -$84.93M(-15.9%) | -$383.98M(+153.8%) |
Sep 2024 | - | -$101.03M(+1.7%) | -$151.31M(-1.3%) |
Jun 2024 | - | -$99.32M(+0.6%) | -$153.36M(+1.3%) |
Mar 2024 | - | -$98.70M(-166.8%) | -$151.37M(+3.0%) |
Dec 2023 | -$146.95M(-53.5%) | $147.74M(-243.3%) | -$146.95M(-60.4%) |
Sep 2023 | - | -$103.08M(+5.9%) | -$371.30M(+4.3%) |
Jun 2023 | - | -$97.33M(+3.2%) | -$356.05M(+5.6%) |
Mar 2023 | - | -$94.28M(+23.1%) | -$337.27M(+6.8%) |
Dec 2022 | -$315.90M(-18.0%) | -$76.61M(-12.8%) | -$315.90M(+5.3%) |
Sep 2022 | - | -$87.83M(+11.8%) | -$300.14M(+7.1%) |
Jun 2022 | - | -$78.55M(+7.7%) | -$280.19M(+8.2%) |
Mar 2022 | - | -$72.91M(+19.8%) | -$258.95M(-32.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$385.01M(+200.7%) | -$60.85M(-10.4%) | -$385.01M(+5.9%) |
Sep 2021 | - | -$67.88M(+18.5%) | -$363.69M(+9.6%) |
Jun 2021 | - | -$57.30M(-71.2%) | -$331.91M(+10.7%) |
Mar 2021 | - | -$198.97M(+403.4%) | -$299.75M(+134.1%) |
Dec 2020 | -$128.03M(+78.7%) | -$39.53M(+9.5%) | -$128.03M(+12.4%) |
Sep 2020 | - | -$36.10M(+43.6%) | -$113.87M(+20.0%) |
Jun 2020 | - | -$25.14M(-7.8%) | -$94.88M(+9.6%) |
Mar 2020 | - | -$27.25M(+7.4%) | -$86.53M(+20.8%) |
Dec 2019 | -$71.65M(-38.3%) | -$25.37M(+48.2%) | -$71.65M(+1.0%) |
Sep 2019 | - | -$17.12M(+1.9%) | -$70.94M(-43.6%) |
Jun 2019 | - | -$16.79M(+35.7%) | -$125.82M(+15.4%) |
Mar 2019 | - | -$12.37M(-49.8%) | -$109.02M(+12.8%) |
Dec 2018 | -$116.09M | -$24.66M(-65.7%) | -$96.65M(+34.3%) |
Sep 2018 | - | -$71.99M | -$71.99M |
FAQ
- What is Beam Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Beam Therapeutics?
- What is Beam Therapeutics annual EBITDA year-on-year change?
- What is Beam Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Beam Therapeutics?
- What is Beam Therapeutics quarterly EBITDA year-on-year change?
- What is Beam Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Beam Therapeutics?
- What is Beam Therapeutics TTM EBITDA year-on-year change?
What is Beam Therapeutics annual EBITDA?
The current annual EBITDA of BEAM is -$383.98M
What is the all time high annual EBITDA for Beam Therapeutics?
Beam Therapeutics all-time high annual EBITDA is -$71.65M
What is Beam Therapeutics annual EBITDA year-on-year change?
Over the past year, BEAM annual EBITDA has changed by -$237.02M (-161.29%)
What is Beam Therapeutics quarterly EBITDA?
The current quarterly EBITDA of BEAM is -$113.76M
What is the all time high quarterly EBITDA for Beam Therapeutics?
Beam Therapeutics all-time high quarterly EBITDA is $147.74M
What is Beam Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BEAM quarterly EBITDA has changed by -$15.06M (-15.26%)
What is Beam Therapeutics TTM EBITDA?
The current TTM EBITDA of BEAM is -$399.03M
What is the all time high TTM EBITDA for Beam Therapeutics?
Beam Therapeutics all-time high TTM EBITDA is -$70.94M
What is Beam Therapeutics TTM EBITDA year-on-year change?
Over the past year, BEAM TTM EBITDA has changed by -$247.66M (-163.61%)